Survival curves. (A) PTLD-free survival (all patients). (B) PTLD-free survival stratified by EBV serostatus of patient and donor (high-risk, D+/R−; intermediate-risk, D−/R+, D+/R+; low-risk, D−/R−). (C) PTLD-free survival stratified by high-risk organ transplant type (lung, multivisceral/intestinal). (D) PTLD-free survival stratified by peak EBV viral load of >1176 vs ≤1176 IU/mL. (E) PTLD-free survival stratified by peak plasma EBV viral load (IU/mL): detected, <1000, 1000 to 4000, and >4000.
Figure 6.

Survival curves. (A) PTLD-free survival (all patients). (B) PTLD-free survival stratified by EBV serostatus of patient and donor (high-risk, D+/R−; intermediate-risk, D−/R+, D+/R+; low-risk, D−/R−). (C) PTLD-free survival stratified by high-risk organ transplant type (lung, multivisceral/intestinal). (D) PTLD-free survival stratified by peak EBV viral load of >1176 vs ≤1176 IU/mL. (E) PTLD-free survival stratified by peak plasma EBV viral load (IU/mL): detected, <1000, 1000 to 4000, and >4000.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal